FI900056A - Tioformadderivat. - Google Patents

Tioformadderivat. Download PDF

Info

Publication number
FI900056A
FI900056A FI900056A FI900056A FI900056A FI 900056 A FI900056 A FI 900056A FI 900056 A FI900056 A FI 900056A FI 900056 A FI900056 A FI 900056A FI 900056 A FI900056 A FI 900056A
Authority
FI
Finland
Prior art keywords
aryl
alkyl
carbamoyl
represents hydrogen
arylco
Prior art date
Application number
FI900056A
Other languages
English (en)
Finnish (fi)
Other versions
FI900056A0 (fi
Inventor
Malcolm Norman Palfreyman
Nigel Vicker
Roger John Aitchison Walsh
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898900295A external-priority patent/GB8900295D0/en
Priority claimed from GB898900245A external-priority patent/GB8900245D0/en
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of FI900056A0 publication Critical patent/FI900056A0/fi
Publication of FI900056A publication Critical patent/FI900056A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Insulating Materials (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Separation, Recovery Or Treatment Of Waste Materials Containing Plastics (AREA)
  • Steroid Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
FI900056A 1989-01-06 1990-01-05 Tioformadderivat. FI900056A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898900295A GB8900295D0 (en) 1989-01-06 1989-01-06 New compositions of matter
GB898900245A GB8900245D0 (en) 1989-01-06 1989-01-06 New compositions of matter

Publications (2)

Publication Number Publication Date
FI900056A0 FI900056A0 (fi) 1990-01-05
FI900056A true FI900056A (fi) 1990-07-07

Family

ID=26294807

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900056A FI900056A (fi) 1989-01-06 1990-01-05 Tioformadderivat.

Country Status (16)

Country Link
US (1) US5104883A (pt)
EP (1) EP0377532B1 (pt)
JP (1) JPH02258760A (pt)
KR (1) KR900011727A (pt)
AT (1) ATE78814T1 (pt)
AU (1) AU4761290A (pt)
CA (1) CA2007281A1 (pt)
DE (1) DE69000224T2 (pt)
DK (1) DK0377532T3 (pt)
ES (1) ES2043294T3 (pt)
FI (1) FI900056A (pt)
GR (1) GR3005616T3 (pt)
HU (1) HUT53615A (pt)
IL (1) IL92930A0 (pt)
OA (1) OA09434A (pt)
PT (1) PT92796A (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000342D0 (en) * 1990-01-08 1990-03-07 May & Baker Ltd New compositions of matter
GB9002879D0 (en) * 1990-02-08 1990-04-04 May & Baker Ltd New compositions of matter
EP0609442A4 (en) * 1991-10-14 1995-02-08 Eisai Co Ltd THIOFORMAMIDE DERIVATIVE.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2100970B1 (pt) * 1970-07-30 1975-08-01 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
HU900050D0 (en) 1990-03-28
IL92930A0 (en) 1990-09-17
US5104883A (en) 1992-04-14
ATE78814T1 (de) 1992-08-15
DE69000224T2 (de) 1993-01-14
ES2043294T3 (es) 1993-12-16
FI900056A0 (fi) 1990-01-05
KR900011727A (ko) 1990-08-02
JPH02258760A (ja) 1990-10-19
GR3005616T3 (pt) 1993-06-07
DE69000224D1 (en) 1992-09-03
HUT53615A (en) 1990-11-28
EP0377532B1 (en) 1992-07-29
CA2007281A1 (en) 1990-07-06
EP0377532A1 (en) 1990-07-11
OA09434A (en) 1992-10-15
AU4761290A (en) 1990-07-12
PT92796A (pt) 1990-07-31
DK0377532T3 (da) 1992-09-14

Similar Documents

Publication Publication Date Title
DE69827785D1 (de) 1,4-substituierte cyclische aminderivate
PT95389A (pt) Processo para a preparacao de novos derivados pirazolicos com accao anti-inflamatoria
KR900009660A (ko) 신규 화합물들
ES2081563T3 (es) Benzamidas.
DK0378518T3 (da) Adenosinderivater med farmaceutisk aktivitet som antihypertensiva
ES2091212T3 (es) Compuestos de xantina.
ES2168383T3 (es) Derivados de 1,2,3,4-tetrahidroquinoxalindiona y su utilizacion como antagonistas del glutamato receptor.
KR940014318A (ko) 에이즈의 치료에 유용한 에이치아이브이(hiv) 프로테아제 억제제
ES544926A0 (es) Procedimiento de obtencion de 2-amino oxazolinas
NO895023D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminderivater.
ATE78814T1 (de) Thioformamidderivate.
KR890013015A (ko) 복소환 화합물 및 항궤양제
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
DE69714709D1 (de) Cyclische amic-säurederivate

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: MAY & BAKER LIMITED